2026-01-02 - Analysis Report
Here's an analysis of Lam Research (LRCX) based on the data provided:

**0. Overview**

*   **Ticker:** LRCX
*   **Company Name:** Lam Research Corp
*   **Overview:** Lam Research is a global supplier of wafer fabrication equipment and services to the semiconductor industry.

**1. Return Rate vs. S&P 500 (VOO)**

*   **LRCX Cumulative Return:** 220.55%
*   **VOO Cumulative Return:** 105.07%
*   **Divergence:**
    *   **Current:** 115.5
    *   **Relative Divergence:** 93.0

**Analysis:** LRCX has significantly outperformed the S&P 500. The current divergence of 115.5 indicates a strong positive difference in returns. The relative divergence of 93.0 suggests that the current outperformance is near the high end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
|------------|---------|-------|---------|------|--------|
| 2016-2018  | 90.0%   | 69.7% | 60.0%   | 1.6  | 17.2   |
| 2017-2019  | 155.0%  | 82.9% | 113.0%  | 1.7  | 36.9   |
| 2018-2020  | 147.0%  | 82.9% | 114.0%  | 1.5  | 59.5   |
| 2019-2021  | 324.0%  | 82.9% | 248.0%  | 1.6  | 90.7   |
| 2020-2022  | 41.0%   | 85.7% | 22.0%   | 1.6  | 53.0   |
| 2021-2023  | 62.0%   | 85.7% | 33.0%   | 1.8  | 98.8   |
| 2022-2024  | 22.0%   | 84.1% | -8.0%   | 1.9  | 91.1   |
| 2023-2025  | 242.0%  | 86.8% | 174.0%  | 2.0  | 215.9  |

**Analysis:**

*   **CAGR:** Lam Research has delivered high compound annual growth rates (CAGR) in most periods.
*   **MDD:** Maximum Drawdown (MDD) figures are high, indicating significant volatility.
*   **Alpha:**  High positive Alpha values demonstrate significant outperformance compared to its expected return based on Beta. The period from 2022-2024 showed negative alpha, indicating underperformance during this time.
*   **Beta:** Beta values consistently above 1 (ranging from 1.5 to 2.0) mean LRCX is more volatile than the market. The increasing Beta suggests that LRCX's volatility relative to the market has been trending upward.
*   **Cap(B):** Market capitalization has generally increased over the periods.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 171.18
*   **Previous Close:** 173.78
*   **Change:** -1.5
*   **5-day SMA:** 175.246
*   **20-day SMA:** 167.387
*   **60-day SMA:** 156.1555

**Analysis:** The stock price closed slightly lower than the previous day. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This suggests a short-term downward trend that might be reversing as the 20 day SMA has risen above the 60 day SMA recently. The price movement is currently below the 5 day SMA suggesting downward momentum.

**3. Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 52.81 (Neutral)
*   **PPO:** 0.1076
*   **Hybrid Signal:** Buy 90% of cash (4 shares - Safe - MRI:0.80) Dividend_0.26 (Cash Ratio: 0% on 2025-12-03)
*   **Recent (20 days) relative divergence change:** -6.2 (Short-term decline)
*   **Expected Return (%):** 44.19%

**Analysis:**

*   The MRI suggests a high investment recommendation.
*   The RSI indicates a neutral position, neither overbought nor oversold.
*   The PPO is slightly positive, hinting at a possible upward trend.
*   The Hybrid Signal recommends buying, reinforcing the MRI's high investment recommendation.
*   A negative change in relative divergence over the last 20 days points to a recent period of underperformance compared to the S&P 500.
*   The expected return of 44.19% is attractive and represents a potentially high excess return compared to the S&P 500 for long-term investors.

**4. Recent News & Significant Events**

*   **Positive Coverage:** Several articles highlight positive aspects of Lam Research, including Wall Street's bullish outlook and benefits from cyclical demand.
*   **Stock Split:** The discussion around a potential stock split could impact the stock's liquidity and appeal to smaller investors.
*   **Tech Pullback:** One article mentions Lam Research being affected by a year-end tech pullback.
*   **Stock Price Down:** An article reports a 1.5% decrease in stock price, which aligns with the data provided in point 2.

**Analysis:** The news sentiment is mixed. While many articles are positive, the tech pullback and stock price decline suggest potential short-term headwinds. The discussion of a stock split could create positive momentum.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.79)
*   **Target Price:** Average: 169.83, High: 210.00, Low: 115.00

**Analysis:** The strong buy consensus and high target price of $210 suggest analysts are optimistic about Lam Research's future performance. The current price is trading around the average target price.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-24 | 1.24 | 5.32 B$   |
| 2025-04-25 | 1.04 | 4.72 B$   |
| 2025-01-31 | 0.93 | 4.38 B$   |
| 2024-10-28 | 0.86 | 4.17 B$   |
| 2025-10-24 | 0.86 | 4.17 B$   |

**Analysis:**  Both EPS (Earnings Per Share) and revenue generally show an upward trend.  However, there is duplicated data in the table. Removing it, the correct table will be:

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-24 | 1.24 | 5.32 B$   |
| 2025-04-25 | 1.04 | 4.72 B$   |
| 2025-01-31 | 0.93 | 4.38 B$   |
| 2024-10-28 | 0.86 | 4.17 B$   |

Recent earnings has been consistently improved since 2024-10-28. This growth in earnings and revenue suggests positive financial performance.

**6. Financial Information (Revenue, Profitability, Capital)**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-09-30   | $5.32B    | 50.43%         |
| 2025-06-30   | $5.17B    | 50.08%         |
| 2025-03-31   | $4.72B    | 49.02%         |
| 2024-12-31   | $4.38B    | 47.37%         |
| 2024-09-30   | $4.17B    | 48.05%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $10.19B   | 15.39%   |
| 2025-06-30   | $9.86B    | 17.44%   |
| 2025-03-31   | $9.51B    | 13.99%   |
| 2024-12-31   | $8.81B    | 13.52%   |
| 2024-09-30   | $8.47B    | 13.18%   |

**Analysis:**

*   **Revenue:** Increasing steadily, indicating business growth.
*   **Profit Margin:** Consistently high and above 47%, showing strong profitability.
*   **Equity:** Increasing, demonstrating a healthy balance sheet.
*   **ROE (Return on Equity):** Indicates decent returns generated on shareholders' equity.

**7. Comprehensive Analysis (Summary)**

Lam Research has delivered strong historical performance, outperforming the S&P 500 significantly. Recent news indicates positive expectations and financial performance, particularly with earnings and revenue growth. A recent decline in the stock price is a slight concern but needs to be monitored. Analyst consensus and a high market risk indicator (MRI) further support an investment.

*   **Strengths:**
    *   Strong historical performance (high CAGR, Alpha).
    *   Increasing revenue and profit margins.
    *   Positive analyst consensus.
    *   High MRI (High Investment Recommended).
    *   High expected returns (44.19%).
*   **Weaknesses:**
    *   High historical volatility (MDD, Beta).
    *   Recent short-term price decline.
    *   Negative recent relative divergence change.

**Overall:**

Based on the data, Lam Research appears to be a promising investment opportunity. The company's robust financial performance, strong growth prospects, and positive analyst sentiment outweigh the concerns about short-term volatility and recent price decline. However, investors should be aware of the potential for significant price swings due to the stock's high beta. The recent relative divergence decline should also be monitored.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.